Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:569-570 (15 March), doi:10.1136/bmj.39513.576701.80
International collaboration to set standards and methods is urgently needed
| The first 150 words of the full text of this article appear below. |
Recent technological developments have created a new generation of laboratory diagnostics, which promise to provide better ways of detecting diseases and monitoring response to treatment. These tests create the possibility of earlier and more accurate diagnosis, and of shifting health care from hospitals to the community—making it more effective, efficient, and accessible. But two recent reports—one of which is published this week—highlight the relatively low importance given by clinicians and policy makers to evaluating laboratory diagnostic tests.1 2 In an accompanying analysis, Melzer and colleagues outline the problems caused by this, specifically relating to the evaluation of genetic tests, and propose ways of overcoming them.3
So how should we evaluate tests? First, we must be clear about the purpose of the test—whether it is meant to diagnose, monitor, guide prognosis or treatment, or predict risk. Then the context in which it is used needs to be specified—for example, the disorder or
Tom Walley, director, National Institute for Health Research health technologies assessment programme
1 University of Liverpool, Liverpool L69 3GF
twalley@liv.ac.uk
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+